亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

濟南偉都化工有限公司銷售部  

過氧化脲,三乙基硼氫化鋰,米格列醇,他克莫司,奧利司他,阿尼西坦,七氟烷,異氟烷

搜索
新聞中心
  • 暫無新聞
產品分類
聯系方式
  • 聯系人:蘇珊
  • 電話:0531-88873476
  • 郵件:13969173319@163.com
  • 傳真:0531-88873470
  • QQ:1966745892
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 利莫那班,168273-06-1,Rimonabant
利莫那班,168273-06-1,Rimonabant
單價 10.00 / 公斤對比
銷量 暫無
發貨 山東濟南市付款后3天內
庫存 1000公斤起訂1公斤
品牌 濟南偉都
型號 168273-06-1
規格 99%
過期 長期有效
更新 2013-07-03 17:46
 
詳細信息


利莫那班,168273-06-1,Rimonabant 

英文名  Rimonabant
別名  5-(4-Chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-piperidinopyrazole-3-carboxamide
產品名稱  利莫那班; 5-(4-氯苯基)-1-(2,4-二氯苯基)-4-甲基-N-(1-哌啶基)-1H-吡唑-3-甲酰胺

分子式  C22H21Cl3N4O
分子量  463.79
CAS 登錄號  168273-06-1


鹽酸利莫那班  158681-13-1
英文名  Rimonabant hydrochloride
別名  5-(4-Chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-1-piperidinyl-1H-pyrazole-3-carboxamide monohydrochloride
產品名稱  鹽酸利莫那班; 5-(4-氯苯基)-1-(2,4-二氯苯基)-4-甲基-N-(1-哌啶基)-1H-吡唑-3-甲酰胺鹽酸鹽
 
分子結構  
 
分子式  C22H21Cl3N4O.HCl
分子量  500.25
CAS 登錄號  158681-13-1
   
物理化學性質
 
熔點  230-240 ºC


利莫那班羧酸  162758-35-2

英文名:Rimonabant Carboxylic Acid
利莫那班羧酸化學名:5-(4-氯苯基)-1-1(2,4-二氯苯基)-4-甲基-吡唑-3-甲酸
5-(4-chlorophenyl)-1-1(2,4-dichlorophenyl)-4-methyl-pyrazole-3-carbox-ylic acid
CAS號:162758-35-2
分子式:C17H11Cl3N2O2
外觀:白色粉末
純度:≥99%
主要用途:用于合成利莫那班

©2025 濟南偉都化工有限公司銷售部 版權所有   技術支持:化工網   訪問量:20007  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |